Alcoholic Liver Disease (ALD)
Keywords:
Alcoholic Liver Disease, Hepatic Steatosis, Alcoholic Hepatitis, CirrhosisAbstract
Alcoholic Liver Disease (ALD) is a major public health problem
in Portugal. Alcohol is the most common drug of abuse in our
country. The author present a literature review about this subject,
approaching ALD epidemiology, pathogenesis of alcoholic liver
damage, diagnosis, and fi nally the ALD range, from hepatic
steatosis, to alcoholic hepatitis and fi nally liver cirrhosis. We also
refer to recent advances in treatment.
Downloads
References
Mª Lucília Mercês de Mello et al. Álcool e problemas ligados ao álcool em Portugal: Direcção Geral de Saúde 2001.
World Drink Trends 2004, WARC Ltd, ISBN: 1-84116-152-7.
World Drink Trends 1998, NTC publications, ISBN: 1-84116-016-4.
World Drink Trends 2002, WARC Ltd, UK, ISBN: 1-84116-105-5.
Adams WL et al. Alcohol-related hospitalizations of elderly people. Prevalence and geographic variation in the United States. JAMA 1993;270(17):2055.
Dias P et al. Patologia relacionada com o álcool no internamento de um Serviço de Medicina Interna. Med-interna. 2005; 9 (19): 32-36.
Risco de morrer em Portugal 2001, disponível em www.dgsaude.pt.
Sheila Sherlock & James Dooley, Diseases of the Liver and Biliary System, 11ª edição, Blackwell Publishing. 2002: 381-398.
Lelbach WK. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann N Y Acad Sci. 1975;252:85-105.
Mann R et al. The Epidemiology of Alcoholic Liver Disease, disponível em http://eeeniaa.nih.gov/publications/arh27-3/209-219.htm.
Bellentani S et al. The spectrum of liver disease in the general population: lesson from the Dionysos study. J Hepatol. 2001 ;35(4):531-537.
Bode C et al. Effect of the type of beverage and meat consumed by alcoholics with alcoholic liver disease. Alcohol Clin Exp Res, 1998;22(8):1803-1805.
Pelletier S et al. Wine consumption is not associated with a decreased risk of alcoholic cirrhosis in heavy drinkers. Alcohol Alcohol 2002; 37(6):618-621.
Lieber C: Medical Disorders of Alcoholism. N Engl J Med 1995; 333:1058-1065.
Cederbaum AI: Effects of alcohol on hepatic mitochondrial function and DNA. Grastroenterology. 1999; 117 (1): 265-269.
Vidali M et al. Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease. Hepatology 2003 ;37(2):410-419.
Hoeck, JB. Endotoxin and alcoholic liver disease: tolerance and susceptibility. Hepatology 1999 ;29(5):1602-1604.
Han DW: Intestinal endotoxemia as a pathogenic mechanism in liver failure. World J Gastroenterol 2002;8(6);961-965.
Rao RK et al. Recent advances in Alcoholic Liver Disease: Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2004;286(6):G881-884.
Morgan MY et al. Sex-related differences among 100 patients with alcoholic liver disease. Br Med J 1977;1(6066):939-941.
Marshall AW et al. Ethanol elimination in males and females: relationship to menstrual cycle and body composition. Hepatology 1983 ;3(5):701-706.
Chrostek L et al. Gender-related differences in hepatic activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in humans. J Clin Lab Anal 2003;17(3):93-96.
Tanaka F et al. High incidence of ADH2*1/ALDH2*1 genes among Japanese alcohol dependents and patients with alcoholic liver disease. Hepatology 1996;23(2):234-239.
Borras E et al. Genetic polymorphism of alcohol dehydrogenase in europeans: the ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1. Hepatology 2000 ;31(4):984-989.
Savolainen VT et al. Polymorphism in the cytochrome P450 2E1 gene and the risk of alcoholic liver disease. J Hepatol 1997 ;26(1):55-61.
Grove J et al. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 1997 ;26(1):143-146.
Casanova P et al. PGA: Marcador biológico de doença hepática alcoólica. Arq-Med 1996;10(1):10-13.
Casanova P : Esteatose Hepática Alcoólica. Álcool e Aparelho Digestivo - Biblioteca Gastroenterológica. Ed. Única, Permanyer Portugal. 2000: 79-90. ESBN: 972-733-066-5.
Mihas AA et al. Laboratory markers of ethanol intake and abuse: a critical appraisal. Am J Med Sci 1992 ;303(6):415-428.
Santos R: Fibrose Hepática Alcoólica.. Álcool e Aparelho Digestivo - Biblioteca Gastroenterológica. Ed. Única, Permanyer Portugal. 2000: 91-115. ISBN: 972-733-066-5.
Poynard T et al. A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology 1991;100(5 Pt 1):1397-1402
Huang Y et al. Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. J Hepatol 1996 ;24(4):377-384.
Fromerty B et al: Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis. Gastroenterology 1995 ;108(1):193-200.
Santos A: Hepatite Alcoólica Aguda. Álcool e Aparelho Digestivo - Biblioteca Gastroenterológica. Ed. Única, Permanyer Portugal. 2000: 128-46. ISBN: 972-733-066-5.
Harrison´s Principles of Internal Medicine, 16th edition, McGraw-Hill 2005.
Dunn W et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 2005 ;41(2):353.
Cabre E et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology 1990;98(3):715-720.
Carithers RL et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med
;110(9):685-690.
Akriviadis E et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119(6):1637-1648.
Tilg H et al. Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol 2003 ;38(4):419-425.
Naveau S et al. A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 2004;39(5):1390-1397.
Heemann U et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002 ;36(4
Pt 1):949-958.
Stephen F et al The management of alcoholic liver disease. Journal of Hepatology, Vol. 38 (S1) (2003) pp. S2-S13.
Porto A: Cirrose hepática alcoólica. Álcool e Aparelho Digestivo - Biblioteca Gastroenterológica. Ed. Única, Permanyer Portugal. 2000: 117-27. ISBN: 972-733-066-5.
Henriques, P: Terapêutica Médica da Cirrose Hepática. Coimbra Med. 1981; 2 (1): 77-81.
Orrego H et al. Long-term treatment of alcoholic liver disease with propylthiouracil. N Engl J Med 1987;317(23):1421-1427.
Orrego H et al. Long-term treatment of alcoholic liver disease with propylthiouracil. Part 2: Influence of drop-out rates and of continued alcohol consumption in a clinical trial. J Hepatol 1994 ;20(3):343-349.
Mato JM et al. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol 1999;30(6):1081-1089
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
